Abnormal peripheral lymphocyte function in c-abl mutant mice

被引:35
作者
Hardin, JD
Boast, S
Schwartzberg, PL
Lee, G
Alt, FW
Stall, AM
Goff, SP
机构
[1] COLUMBIA UNIV, COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA
[2] COLUMBIA UNIV, COLL PHYS & SURG, HOWARD HUGHES MED INST, NEW YORK, NY 10032 USA
[3] HOWARD HUGHES MED INST, BOSTON, MA 02115 USA
关键词
D O I
10.1006/cimm.1996.0220
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The proto-oncogene c-abl encodes a tyrosine kinase that is hypothesized to function in proliferation-stimulatory signaling pathways. Previous work on mice homozygous for targeted mutations in the c-abl gene (abl(m1) and abl(2) mutant strains) has demonstrated multiple defects, including a susceptibility to infections that results in a high mortality rate after weaning. FAGS analysis of the hemopoietic system of c-abl mutants demonstrated variable reductions in B and T lymphocytes in adult bone marrow, thymus, spleen, and peripheral blood, In addition, bone marrow from mutants showed a decreased ability to respond to interleukin-7. We further found that B cells from abl(ml) mice had a reduced ability to respond to lipopolysaccharide (decreased to 10% of control response) that was dependent on the culture conditions and the tissue of origin of B cells. Peripheral blood from the mutants also had a reduced response to the T cell mitogen concanavalin A, Immune response in abl(m1) mice as determined by the mixed lymphocyte response and the sheep red blood cell plaque-forming assay was grossly normal. These findings suggest that although specific signaling pathways in lymphocytes may involve c-Abl, the immune system can function in the absence of a normal c-abl gene product. (C) 1996 Academic Press, Inc.
引用
收藏
页码:100 / 107
页数:8
相关论文
共 54 条
[11]   PHILADELPHIA CHROMOSOMAL BREAKPOINTS ARE CLUSTERED WITHIN A LIMITED REGION, BCR, ON CHROMOSOME-22 [J].
GROFFEN, J ;
STEPHENSON, JR ;
HEISTERKAMP, N ;
DEKLEIN, A ;
BARTRAM, CR ;
GROSVELD, G .
CELL, 1984, 36 (01) :93-99
[12]   BONE-MARROW B-LYMPHOCYTE DEVELOPMENT IN C-ABL-DEFICIENT MICE [J].
HARDIN, JD ;
BOAST, S ;
SCHWARTZBERG, PL ;
LEE, G ;
ALT, FW ;
STALL, AM ;
GOFF, SP .
CELLULAR IMMUNOLOGY, 1995, 165 (01) :44-54
[13]   A BCR-V-ABL ONCOGENE INDUCES LYMPHOMAS IN TRANSGENIC MICE [J].
HARIHARAN, IK ;
HARRIS, AW ;
CRAWFORD, M ;
ABUD, H ;
WEBB, E ;
CORY, S ;
ADAMS, JM .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (07) :2798-2805
[14]   ACTIVATION AND PROLIFERATION SIGNALS IN MOUSE B-CELLS .1. A COMPARISON OF THE CAPACITY OF ANTI-IG ANTIBODIES OR PHORBOL MYRISTIC ACETATE TO ACTIVATE B-CELLS FROM CBA/N OR NORMAL MICE INTO G1 [J].
HAWRYLOWICZ, CM ;
KEELER, KD ;
KLAUS, GGB .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1984, 14 (03) :244-250
[15]   ACUTE-LEUKEMIA IN BCR/ABL TRANSGENIC MICE [J].
HEISTERKAMP, N ;
JENSTER, G ;
TENHOEVE, J ;
ZOVICH, D ;
PATTENGALE, PK ;
GROFFEN, J .
NATURE, 1990, 344 (6263) :251-253
[16]  
HOWARD M, 1986, J IMMUNOL, V136, P4531
[17]   N-TERMINAL MUTATIONS ACTIVATE THE LEUKEMOGENIC POTENTIAL OF THE MYRISTOYLATED FORM OF C-ABL [J].
JACKSON, P ;
BALTIMORE, D .
EMBO JOURNAL, 1989, 8 (02) :449-456
[18]   DEFECTIVE COLONY FORMATION BY B LYMPHOCYTES FROM CBA-N AND C3H-HEJ MICE [J].
KINCADE, PW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 145 (02) :249-263
[19]  
KINCADE PW, 1989, ANNU REV IMMUNOL, V7, P111, DOI 10.1146/annurev.iy.07.040189.000551